Published in JAMA on February 23, 2000
Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58
Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis. Am J Epidemiol (2008) 2.91
Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol (2002) 2.18
High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol (2002) 1.83
Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control (2009) 1.52
Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya. J Low Genit Tract Dis (2012) 1.50
Two-week versus six-month sampling interval in a short-term natural history study of oral HPV infection in an HIV-positive cohort. PLoS One (2010) 1.49
Long-term incidence of cervical cancer in women with human immunodeficiency virus. Cancer (2009) 1.42
Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr (2007) 1.39
Natural history of anal vs oral HPV infection in HIV-infected men and women. J Infect Dis (2013) 1.37
The impact of antiretroviral therapy on HPV and cervical intraepithelial neoplasia: current evidence and directions for future research. Infect Agent Cancer (2010) 1.32
Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort. AIDS (2011) 1.32
Knowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in Kenya. PLoS One (2012) 1.31
Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2009) 1.31
Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res (Phila) (2011) 1.27
Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study. BMC Cancer (2009) 1.23
Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ (2003) 1.20
The prevalence of cervical cytology abnormalities and human papillomavirus in women infected with the human immunodeficiency virus. Infect Agent Cancer (2009) 1.10
Cervical cancer risk factors among HIV-infected Nigerian women. BMC Public Health (2013) 1.07
Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa. J Int AIDS Soc (2012) 1.05
Detection of human papillomavirus DNA in urine specimens from human immunodeficiency virus-positive women. J Clin Microbiol (2002) 1.05
Immunogenicity and safety of the human papillomavirus 6, 11, 16, 18 vaccine in HIV-infected young women. Clin Infect Dis (2013) 1.05
Barriers to recommended gynecologic care in an urban United States HIV clinic. J Womens Health (Larchmt) (2010) 1.03
Could human papillomaviruses be spread through blood? J Clin Microbiol (2005) 1.02
Antiretroviral-based HIV-1 prevention: antiretroviral treatment and pre-exposure prophylaxis. Antivir Ther (2012) 1.02
Effects of smoking on non-AIDS-related morbidity in HIV-infected patients. Clin Infect Dis (2013) 1.01
Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States. J Womens Health (Larchmt) (2010) 1.01
HIV women's health: a study of gynecological healthcare service utilization in a U.S. urban clinic population. J Womens Health (Larchmt) (2008) 0.97
Immunologic treatments for precancerous lesions and uterine cervical cancer. J Exp Clin Cancer Res (2014) 0.96
Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol (2003) 0.95
Risk factors for nonadherence with Pap testing in HIV-infected women. J Womens Health (Larchmt) (2011) 0.92
The prevalence of precancerous cervical cancer lesion among HIV-infected women in southern Ethiopia: a cross-sectional study. PLoS One (2013) 0.91
Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy. HIV Med (2012) 0.91
Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil. AIDS Patient Care STDS (2015) 0.90
Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach. Open Virol J (2012) 0.89
Integrating cervical cancer screening with HIV care in a district hospital in Abuja, Nigeria. Niger Med J (2013) 0.89
The relationship between cocaine use and human papillomavirus infections in HIV-seropositive and HIV-seronegative women. Infect Dis Obstet Gynecol (2008) 0.88
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3. Br J Cancer (2003) 0.86
Cervical cancer screening adherence among HIV-positive female smokers from a comprehensive HIV clinic. AIDS Behav (2014) 0.86
Cervical cytological changes in HIV-infected patients attending care and treatment clinic at Muhimbili National Hospital, Dar es Salaam, Tanzania. Infect Agent Cancer (2012) 0.86
Prevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination. J Acquir Immune Defic Syndr (2012) 0.85
HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infect Agent Cancer (2008) 0.85
High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study. Int J STD AIDS (2014) 0.84
Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women. J Womens Health (Larchmt) (2011) 0.84
Cervical cancer screening and treatment of cervical intraepithelial neoplasia in female sex workers using "screen and treat" approach. Int J Womens Health (2015) 0.83
Gynecologic issues in the HIV-infected woman. Infect Dis Clin North Am (2008) 0.83
Prevalence and cumulative incidence of abnormal cervical cytology among HIV-infected Thai women: a 5.5-year retrospective cohort study. BMC Infect Dis (2011) 0.82
Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy. Infect Agent Cancer (2009) 0.81
Human papillomavirus detection in women with and without human immunodeficiency virus infection in Colombia. BMC Cancer (2014) 0.80
Association between human papillomavirus and human T-lymphotropic virus in indigenous women from the Peruvian Amazon. PLoS One (2012) 0.80
HPV-11 associated metastatic cervical cancer. Gynecol Oncol Case Rep (2011) 0.79
Review of HIV-Related Cytopathology. Patholog Res Int (2011) 0.79
Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic. AIDS Care (2014) 0.79
Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea. J Korean Med Sci (2013) 0.78
Impact of Widespread Cervical Cancer Screening: Number of Cancers Prevented and Changes in Race-specific Incidence. Am J Clin Oncol (2016) 0.78
Thirty years later: pregnancies in females perinatally infected with human immunodeficiency virus-1. AIDS Res Treat (2012) 0.78
Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion. Oncoimmunology (2015) 0.78
Cancer prevention in HIV-infected populations. Semin Oncol (2015) 0.77
Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010. J Womens Health (Larchmt) (2013) 0.77
Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India. Indian J Med Res (2016) 0.77
Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort. J Pediatr Adolesc Gynecol (2011) 0.77
Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda. PLoS One (2013) 0.77
Differential Gene Expression Landscape of Co-Existing Cervical Pre-Cancer Lesions Using RNA-seq. Front Oncol (2014) 0.76
Complications of common gynecologic surgeries among HIV-infected women in the United States. Infect Dis Obstet Gynecol (2012) 0.76
Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models of human papillomavirus-associated (pre)neoplastic epithelial lesions. Antimicrob Agents Chemother (2004) 0.76
Genital and oral human papillomavirus infection in a patient from the group of women who have sex with women. Clinics (Sao Paulo) (2010) 0.75
Knowledge and Awareness of Cervical Cancer among HIV-Infected Women in Ethiopia. Obstet Gynecol Int (2016) 0.75
Effect of highly active antiretroviral therapy (HAART) and menopause on risk of progression of cervical dysplasia in human immune-deficiency virus- (HIV-) infected women. Infect Dis Obstet Gynecol (2013) 0.75
Time trend analysis of cervical high-risk human papillomavirus (HPV) in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil: the rise of non-16/18 HPV. Int J Infect Dis (2015) 0.75
Antibody responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay. J Acquir Immune Defic Syndr (2017) 0.75
Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy. Viruses (2017) 0.75
A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA (1996) 4.38
Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med (1997) 4.00
HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med (1993) 3.78
Substance use and high-risk sex among men who have sex with men: a national online study in the USA. AIDS Care (2004) 3.44
Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA (2001) 3.26
Heterosexually transmitted human immunodeficiency virus infection among pregnant women in a rural Florida community. N Engl J Med (1992) 3.08
The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N Engl J Med (1989) 2.58
Relation between ambient air pollution and low birth weight in the Northeastern United States. Environ Health Perspect (2001) 2.44
Women at a sexually transmitted disease clinic who reported same-sex contact: their HIV seroprevalence and risk behaviors. Am J Public Health (1995) 2.34
Epidemiology of women with AIDS in the United States, 1981 through 1990. A comparison with heterosexual men with AIDS. JAMA (1991) 2.19
Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst (1977) 2.15
A city-wide outbreak of a multiple-drug-resistant strain of Mycobacterium tuberculosis in New York. Int J Tuberc Lung Dis (1997) 2.14
Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis (1999) 2.07
Possible nosocomial transmission of HIV. Lancet (1994) 2.05
Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. Am J Respir Crit Care Med (1996) 1.93
Investigations of AIDS patients with no previously identified risk factors. JAMA (1988) 1.83
Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol (1995) 1.80
Acquired immunodeficiency syndrome in children: report of the Centers for Disease Control National Surveillance, 1982 to 1985. Pediatrics (1987) 1.76
The association between cigarette smoking and selected HIV-related medical conditions. AIDS (1996) 1.72
Lung cancer among women in north-east China. Br J Cancer (1990) 1.69
Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer (2000) 1.67
Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study. Obstet Gynecol (1994) 1.65
Risk factors in military recruits positive for HIV antibody. N Engl J Med (1986) 1.64
Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst (2000) 1.62
Association between human papillomavirus type and clonal status of cervical squamous intraepithelial lesions. J Natl Cancer Inst (1996) 1.57
Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA (1992) 1.51
A polymerase chain reaction-enzyme-linked immunosorbent assay method for detecting human papillomavirus in cervical carcinomas and high-grade cervical cancer precursors. Obstet Gynecol (1995) 1.50
Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City. J Urban Health (2000) 1.47
Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis (2004) 1.43
Observation of excitonic quenching by long-range dipole-dipole interaction in sequentially doped organic phosphorescent host-guest system. Phys Rev Lett (2007) 1.40
Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis (2001) 1.38
A cost-effective training tool for flexor tendon repair: pig's trotters. J Plast Reconstr Aesthet Surg (2006) 1.38
Loop electrosurgical excision procedure for CIN. Am Fam Physician (1992) 1.38
Improved methods for culturing rat glomerular cells. Kidney Int (1984) 1.36
Binding and internalization of heparin by vascular smooth muscle cells. J Cell Physiol (1985) 1.35
Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. J Infect Dis (2000) 1.33
Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Womens Health (Larchmt) (2005) 1.30
A neglected lesbian health concern: cervical neoplasia. J Fam Pract (1996) 1.29
Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes (1992) 1.29
Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. J Fam Pract (1998) 1.27
Controversies in the management of low-grade cervical intraepithelial neoplasia. Cancer (1993) 1.26
Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study. J Reprod Med (2001) 1.20
Regulation of vascular smooth muscle cell growth by heparin and heparan sulfates. Semin Thromb Hemost (1987) 1.20
Differential subtraction chain, a method for identifying differences in genomic DNA and mRNA. Nucleic Acids Res (1999) 1.18
Transmission of HIV in Belle Glade, Florida: lessons for other communities in the United States. Science (1988) 1.17
Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? J Fam Pract (1998) 1.17
Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE. Am J Public Health (2001) 1.17
Assessment of the cervix after acetic acid wash: inter-rater agreement using photographs. Obstet Gynecol (2002) 1.16
Tumor-ratio-metastasis staging system as an alternative to the 7th edition UICC TNM system in gastric cancer after D2 resection--results of a single-institution study of 1343 Chinese patients. Ann Oncol (2011) 1.16
Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells. J Cell Biol (1989) 1.15
Conventional cervical cytologic smears vs. ThinPrep smears. A paired comparison study on cervical cytology. Acta Cytol (1997) 1.12
The etiology of lung cancer in nonsmoking females in Harbin, China. Lung Cancer (1996) 1.11
Molecular biology of cervical cancer and its precursors. Cancer (1995) 1.11
The epidemic of AIDS and HIV-1 infection among heterosexuals in New York City. AIDS (1990) 1.11
Rates of aggregation, loss of anchorage dependence, and tumorigenicity of cultured cells. Proc Natl Acad Sci U S A (1977) 1.11
Human papillomavirus infection in human immunodeficiency virus-seropositive women. Obstet Gynecol (1995) 1.11
Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol (1995) 1.07
Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF. J Cell Physiol (1985) 1.07
Growth mechanism of tubular ZnO formed in aqueous solution. Nanotechnology (2006) 1.05
Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. Am J Obstet Gynecol (1996) 1.05
Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. Fertil Steril (2001) 1.02
Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul (1990) 1.01
Cervical intraepithelial neoplasia in women infected with the human immunodeficiency virus: outcome after loop electrosurgical excision. Gynecol Oncol (1994) 1.00
Screening for depressive symptoms in an online sample of men who have sex with men. AIDS Care (2008) 1.00
The implications of national health insurance for ambulatory care services in New York City. Bull N Y Acad Med (1977) 0.98
Cost effectiveness of human papillomavirus testing to augment cervical cancer screening in women infected with the human immunodeficiency virus. Am J Med (2001) 0.97
Homelessness and TB: a study in failure. J Law Med Ethics (1994) 0.97
Increased adhesiveness of Down syndrome fetal fibroblasts in vitro. Proc Natl Acad Sci U S A (1984) 0.96
Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS (1996) 0.95
Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera. Contraception (1999) 0.95
How important is race/ethnicity as an indicator of risk for specific AIDS-defining conditions? J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.95
Increased prevalence of vulvovaginal condyloma and vulvar intraepithelial neoplasia in women infected with the human immunodeficiency virus. Obstet Gynecol (1997) 0.94
Free-standing ZnO-CuO composite nanowire array films and their gas sensing properties. Nanotechnology (2011) 0.92
N-P transition sensing behaviors of ZnO nanotubes exposed to NO2 gas. Nanotechnology (2009) 0.91
Cervical ectopy and the transformation zone measured by computerized planimetry in adolescents. Int J Gynaecol Obstet (1999) 0.91
Human papillomavirus testing and screening. Best Pract Res Clin Obstet Gynaecol (2005) 0.90
The changing AIDS epidemic in New York City: a descriptive birth cohort analysis of AIDS incidence and age at diagnosis. AIDS (1995) 0.89
Health care workers with AIDS. National surveillance update. JAMA (1991) 0.89
Heparin inhibits the attachment and growth of Balb/c-3T3 fibroblasts on collagen substrata. J Cell Physiol (1992) 0.89
Seroprevalence of human immunodeficiency virus type 1 and sexual behaviors in bisexual African-American and Hispanic men visiting a sexually transmitted disease clinic in New York City. Am J Epidemiol (1998) 0.89
HIV infection in heterosexual female intravenous drug users in New York City, 1977-1980. N Engl J Med (1988) 0.87
Two-stage cervical cancer screening: an alternative for resource-poor settings. Am J Obstet Gynecol (2000) 0.87
Metabolic effects of heparin on rat cervical epithelial cells. J Cell Physiol (1987) 0.87